ASOs can downregulate the expression of the encoded sodium channel subunit NaV1.6 and have been shown to decrease seizures and mortality in genetic mouse models of SCN8A developmental and epileptic encephalopathy [4]. The gene discussed is SCN8A; the disease is developmental and epileptic encephalopathy.